WHO ICTRP trial
A study on how AI and doctors agree on safe medicines and doses for ICU patients
CTRI/2025/10/095710 · Clinical Trials Registry India (CTRI) · Recruiting
Key facts
| Trial ID | CTRI/2025/10/095710 |
|---|---|
| Public title | A study on how AI and doctors agree on safe medicines and doses for ICU patients |
| Scientific title | An Observational Longitudinal Study to Explore the Concordance between an Advanced Generative AI Model, Live Clinical Prescription, and a Gold Standard Prescription of Drug Appropriateness, Dosing, and Drug-Drug Interactions in a Medical ICU. - AIM-ICU (AI in Medication Safety ICU Study) |
| Primary sponsor | Medanta- The Medicity |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Recruiting |
| Study type | Observational |
| Countries | India |
| Conditions | Health Condition 1: - Health Condition 2: B999- Unspecified infectious disease |
| Interventions | Intervention1: Nil: Nil Intervention2: Nil: Nil Intervention3: Nil: Nil |
| Registration date | Aug 10, 2025 |
| Target size | 50 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: